The chronic activation of BTK in CLL cells determines the activation of AKT (Protein Kinase B) and ERK (extracellular signal-regulated kinase), which in turn influences cellular proliferation, differentiation, and survival. Here, BTK is linked to B-cell chronic lymphocytic leukemia.